EE180 Cost of First-Line Treatment of Hepatocellular Carcinoma With the Immune Checkpoint Inhibitor-Based Regimens STRIDE and Atezolizumab Plus Bevacizumab in Brazil
Abstract
Authors
Barry Rodgers-Gray Marília Hernani Carolina Meyn Teixeira Ricardo Paranhos Moreira Sr. Ian Keary John Fullarton MELDA DINC Li Sun Kate Keeping Doreen Tay